Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis

Author:

Moran Alexandra1ORCID,Ramos Lorena Flor1,Picado Omar1ORCID,Pendola Fiorella2,Sleeman Danny34,Dudeja Vikas14ORCID,Merchant Nipun14,Yakoub Danny14ORCID

Affiliation:

1. Division of Surgical Oncology; DeWitt Daughtry Family Department of Surgery; University of Miami Leonard M. Miller School of Medicine; Miami Florida

2. Department of Medicine; Blake Medical Center; Bradenton Florida

3. Division of General Surgery; DeWitt Daughtry Family Department of Surgery; University of Miami Leonard M. Miller School of Medicine; Miami Florida

4. Sylvester Comprehensive Cancer Center; University of Miami Leonard M. Miller School of Medicine; Miami Florida

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference36 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. National Comprehensive Cancer Network (NCCN) Guidelines 2016

3. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer,2016

4. Current management of hepatocellular carcinoma;Crissien;Gastroenterol Hepatol,2014

5. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis. A reasonable strategy?;Adam;Ann Surg,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3